CytomX Therapeutics Inc (CTMX)
1.98
-0.06
(-2.94%)
USD |
NASDAQ |
May 10, 16:00
1.92
-0.06
(-3.03%)
After-Hours: 20:00
CytomX Therapeutics Market Cap: 134.09M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 09, 2024 | 138.15M |
May 08, 2024 | 283.75M |
May 07, 2024 | 275.63M |
May 06, 2024 | 295.94M |
May 03, 2024 | 300.01M |
May 02, 2024 | 304.75M |
May 01, 2024 | 347.41M |
April 30, 2024 | 110.39M |
April 29, 2024 | 109.03M |
April 26, 2024 | 107.68M |
April 25, 2024 | 108.35M |
April 24, 2024 | 110.39M |
April 23, 2024 | 113.77M |
April 22, 2024 | 113.10M |
April 19, 2024 | 113.10M |
April 18, 2024 | 117.16M |
April 17, 2024 | 119.19M |
April 16, 2024 | 125.96M |
April 15, 2024 | 133.41M |
April 12, 2024 | 145.60M |
April 11, 2024 | 145.60M |
April 10, 2024 | 142.22M |
April 09, 2024 | 137.48M |
April 08, 2024 | 139.51M |
April 05, 2024 | 139.51M |
Date | Value |
---|---|
April 04, 2024 | 139.51M |
April 03, 2024 | 145.60M |
April 02, 2024 | 144.92M |
April 01, 2024 | 145.60M |
March 28, 2024 | 147.63M |
March 27, 2024 | 148.31M |
March 26, 2024 | 142.89M |
March 25, 2024 | 144.92M |
March 22, 2024 | 142.89M |
March 21, 2024 | 151.70M |
March 20, 2024 | 153.73M |
March 19, 2024 | 147.63M |
March 18, 2024 | 136.80M |
March 15, 2024 | 140.18M |
March 14, 2024 | 139.51M |
March 13, 2024 | 142.22M |
March 12, 2024 | 145.60M |
March 11, 2024 | 169.98M |
March 08, 2024 | 169.30M |
March 07, 2024 | 173.37M |
March 06, 2024 | 182.85M |
March 05, 2024 | 184.20M |
March 04, 2024 | 185.56M |
March 01, 2024 | 179.46M |
February 29, 2024 | 165.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.55M
Minimum
Oct 27 2023
672.32M
Maximum
May 12 2020
269.35M
Average
288.46M
Median
Oct 25 2019
Market Cap Benchmarks
Amgen Inc | 166.37B |
Ocular Therapeutix Inc | 839.74M |
Bristol-Myers Squibb Co | 91.08B |
ACADIA Pharmaceuticals Inc | 2.520B |
Calidi Biotherapeutics Inc | 8.398M |
Market Cap Related Metrics
PS Ratio | 1.444 |
Price | 1.98 |
Earnings Yield | -1.01% |